Remibrutinib Treatment Improves Itch and Sleep in Chronic Spontaneous Urticaria Patients: Phase 2b Study Results

被引：0
|
作者：
Hsu, Connie [1 ]
Snyder, Robert [2 ]
Clore, Lee [3 ]
Jain, Vipul [4 ]
Gimenez-Arnau, Ana [5 ]
Lheritier, Karine [6 ]
Walsh, Pauline [7 ]
Haemmerle, Sibylle [6 ]
Wells, Michael [8 ]
Nikolaev, Ivan [6 ]
Maurer, Marcus [9 ,10 ,11 ,12 ]
机构：
[1] Res Solut Arizona, Phoenix, AZ USA
[2] Riverchase Dermatol, Pembroke Pines, FL USA
[3] Allergy & Asthma Specialists PSC, Owensboro, KY USA
[4] McMaster Univ, Div Clin Immunol & Allergy, Dept Med, Hamilton, ON, Canada
[5] Univ Pompeu Fabra, Hosp Mar IMIM, Dept Dermatol, Barcelona, Spain
[6] Novartis Pharma AG, Basel, Switzerland
[7] Novartis Ireland Ltd, Dublin, Ireland
[8] Novartis Pharmaceut, E Hanover, NJ USA
[9] Charit Univ Med Berlin, Inst Allergol, Urticaria Ctr Reference & Excellence UCARE, Berlin, Germany
[10] Free Univ Berlin, Berlin, Germany
[11] Humboldt Univ, Berlin, Germany
[12] Fraunhofer Inst Translatio, Frankfurt, Germany
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2023年 / 89卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
42939
引用
收藏
页码：AB82 / AB82
页数：1
相关论文
共 50 条
  • [31] The Benefit of Complete Response to Treatment in Patients With Chronic Spontaneous Urticaria-CURE Results
    Kolkhir, Pavel
    Laires, Pedro A.
    Salameh, Pascale
    Asero, Riccardo
    Bizjak, Mojca
    Ko, Mitja
    Dissemond, Joachim
    van Doorn, Martijn
    Hawro, Tomasz
    Kasperska-Zajac, Alicja
    Zajac, Magdalena
    Kocatuerk, Emek
    Peter, Jonny
    Parisi, Claudio A. S.
    Ritchie, Carla A.
    Kulthanan, Kanokvalai
    Tuchinda, Papapit
    Fomina, Daria
    Kovalkova, Elena
    Khoshkhui, Maryam
    Kouzegaran, Samaneh
    Papapostolou, Niki
    Du-Thanh, Aurelie
    Kamegashira, Akiko
    Meshkova, Raisa
    Vitchuk, Alexander
    Bauer, Andrea
    Grattan, Clive
    Staubach, Petra
    Bouillet, Laurence
    Gimenez-Arnau, Ana M.
    Maurer, Marcus
    Weller, Karsten
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2023, 11 (02): : 610 - +
  • [32] Ligelizumab achieves sustained control of chronic spontaneous urticaria symptoms of hives, itch and angioedema: 1-year treatment results
    Bernstein, J. A.
    Baker, D.
    Maurer, M.
    Gimenez-Arnau, A. M.
    Sussman, G.
    Barve, A.
    Hua, E.
    Severin, T.
    Janocha, R.
    ALLERGY, 2019, 74 : 21 - 21
  • [33] Chronic Spontaneous Urticaria in elderly Patients: Patient Characteristics, Comorbidities and Treatment Patterns, Results of the German AWARE Study
    Maurer, M.
    Raap, U.
    Staubach, P.
    Richter-Huhn, G.
    Chaouche, K.
    Chapman-Rothe, N.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2017, 15 : 72 - 73
  • [34] Efficacy and Safety of Rilzabrutinib in Patients With Chronic Spontaneous Urticaria: 12-Week Results From the RILECSU Phase 2 DoseRanging Study
    Maurer, Marcus
    Gimenez-Arnau, Ana
    Ferrucci, Silvia
    Mikol, Vincent
    Sun, Iris
    Mannent, Leda
    Gereige, Jessica
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB373 - AB373
  • [35] Ligelizumab as add-on therapy for patients with H1-antihistamine-refractory chronic spontaneous urticaria: primary results of a placebo- and active-controlled phase 2b dose-finding study
    Maurer, M.
    Gimenez-Arnau, A.
    Sussman, G.
    Loeffler, J.
    Barve, A.
    Severin, T.
    Janocha, R.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 121 - 121
  • [36] IMPROVEMENT IN ITCH CORRELATES WITH IMPROVED SLEEP IN GLIMMER, A PHASE 2B TRIAL OF LINERIXIBAT FOR THE TREATMENT OF CHOLESTATIC PRURITUS IN PRIMARY BILIARY CHOLANGITIS
    Jones, David E.
    von Maltzahn, Robyn
    Smith, Helen
    Walker, Andrew J.
    Fettiplace, James
    Currie, Alexander
    Mayo, Marlyn J.
    Levy, Cynthia
    McLaughlin, Megan
    GASTROENTEROLOGY, 2022, 162 (07) : S1285 - S1285
  • [37] Improvement in itch correlates with improved sleep in GLIMMER, a Phase 2b trial of linerixibat for the treatment of cholestatic pruritus in primary biliary cholangitis
    Jones, David
    von Maltzahn, Robyn
    Smith, Helen
    Thompson, April
    Ferreira-Cornwell, M. Celeste
    McLaughlin, Megan
    Allinder, Matthew
    Haque, Nazneen
    Mayo, Marlyn J.
    Levy, Cynthia
    JOURNAL OF HEPATOLOGY, 2021, 75 : S434 - S435
  • [38] Omalizumab retreatment of patients with chronic idiopathic urticaria / chronic spontaneous urticaria following return of symptoms: primary results of the optima study
    Sussman, G.
    Hebert, J.
    Gulliver, W.
    Lynde, C. W.
    Yang, W.
    Chambenoit, O.
    Vieria, A.
    Detakacsy, F.
    Rihakova, L.
    ALLERGY, 2017, 72 : 327 - 327
  • [39] Effect of Roflumilast Cream (ARQ-151) on Itch and Itch-Related Sleep Loss in Adults with Chronic Plaque Psoriasis: Patient-Reported Itch Outcomes of a Phase 2b Trial
    Stein Gold, Linda
    Alonso-Llamazares, Javier
    Draelos, Zoe D.
    Gooderham, Melinda J.
    Kempers, Steven E.
    Kircik, Leon H.
    Lebwohl, Mark G.
    Papp, Kim A.
    Pariser, David M.
    Toth, Darryl P.
    Yosipovitch, Gil
    Higham, Robert C.
    Feng, Amy
    Berk, David R.
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2023, 24 (02) : 305 - 313
  • [40] Effect of Roflumilast Cream (ARQ-151) on Itch and Itch-Related Sleep Loss in Adults with Chronic Plaque Psoriasis: Patient-Reported Itch Outcomes of a Phase 2b Trial
    Linda Stein Gold
    Javier Alonso-Llamazares
    Zoe D. Draelos
    Melinda J. Gooderham
    Steven E. Kempers
    Leon H. Kircik
    Mark G. Lebwohl
    Kim A. Papp
    David M. Pariser
    Darryl P. Toth
    Gil Yosipovitch
    Robert C. Higham
    Amy Feng
    David R. Berk
    American Journal of Clinical Dermatology, 2023, 24 : 305 - 313
12345